Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia
MS Van Kammen, DA De Sousa, S Poli… - JAMA …, 2021 - jamanetwork.com
Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and
Ad26. COV2. S (Janssen/Johnson & Johnson). Objective To describe the clinical
characteristics and outcome of patients with cerebral venous sinus thrombosis (CVST) after
SARS-CoV-2 vaccination with and without TTS. Design, Setting, and Participants This cohort
study used data from an international registry of consecutive patients with CVST within 28 …
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and
Ad26. COV2. S (Janssen/Johnson & Johnson). Objective To describe the clinical
characteristics and outcome of patients with cerebral venous sinus thrombosis (CVST) after
SARS-CoV-2 vaccination with and without TTS. Design, Setting, and Participants This cohort
study used data from an international registry of consecutive patients with CVST within 28 …